First, while 5ARI therapy may reduce the incidence of low-grade prostate cancer, studies have suggested a possible increased risk of high-grade prostate cancer [59,60]
& Wang, L
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
Reserve purely systemic injection for situations where local access is difficult or when addressing multiple widespread issues
2019 Jun Cristiana Paul, David M Brady
We include a complimentary vial 2ml, 3ml, or 10ml with every peptide order as a courtesy, so you have everything you need for safe reconstitution